Liebermann Juergen
Fertility Centers of Illinois, 900 N Kingsbury RW 6, Chicago, IL, 60610, USA,
Methods Mol Biol. 2015;1257:305-19. doi: 10.1007/978-1-4939-2193-5_12.
Cryopreservation is one of the keystones in clinical infertility treatment. Especially vitrification has become a well-established and widely used routine procedure that allows important expansion of therapeutic strategies when in vitro fertilization (IVF) is used to treat infertility. Vitrification of human blastocysts allows us to maximize the potential for conception from any one in vitro fertilization cycle and prevents wastage of embryos. This goes even further toward to best utilize a patient's supernumerary oocytes after retrieval, maximizing the use of embryos from a single stimulation cycle. The technology may even be used to eliminate fresh embryo transfers for reasons of convenience, uterine receptivity, fertility preservation, preimplantation genetic diagnosis, or emergency management. In this chapter, the application of vitrification technology for cryopreserving human blastocyst will be revealed through step-by-step protocols. The results that are presented using the described protocols underscore the robustness of the vitrification technology for embryo cryopreservation.
冷冻保存是临床不孕症治疗的关键技术之一。尤其是玻璃化冷冻已成为一种成熟且广泛应用的常规程序,当体外受精(IVF)用于治疗不孕症时,它能极大地扩展治疗策略。人类囊胚的玻璃化冷冻使我们能够最大限度地提高每个体外受精周期的受孕潜力,并防止胚胎浪费。这对于在取卵后更好地利用患者多余的卵母细胞、最大限度地利用单个刺激周期产生的胚胎而言更进一步。该技术甚至可因方便性、子宫容受性、生育力保存、植入前基因诊断或应急管理等原因而用于消除新鲜胚胎移植。在本章中,将通过分步方案揭示玻璃化冷冻技术在冷冻保存人类囊胚方面的应用。使用所述方案呈现的结果强调了玻璃化冷冻技术用于胚胎冷冻保存的稳健性。